Search Results 791-800 of 17465 for GLP-1 secretion

  1. Gastroenterology and Hepatology - Clinical trials

    A Study to Evaluate the Effect of Improving Glycemic Control on Gastric Emptying in Type 1 and Type 2 Diabetes Mellitus. Rochester, Minn. The purpose of this ...

  2. Avelumab With Binimetinib, Sacituzumab Govitecan, Or Liposomal Doxorubicin In Treating Patients With Stage IV Or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  3. Evaluating The Safety And Efficacy Of TLD In Patients With COPD - Mayo Clinic

    The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard ...

  4. Glioma - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in ...

  5. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in combination ...

  6. Publications - Craig M. Horbinski, M.D. - Mayo Clinic

    Treatment of Isocitrate Dehydrogenase-Mutant Gliomas. Advances in Oncology. 2025; 5(1):135-150. Sullivan JJ, Chandler JP, Lesniak MS, Tate MC, Sonabend AM ...

  7. Medical Research & Education - Mayo Clinic News Network

    April 1, 2026. Including AI-derived heart fat measurement improves accuracy of cardiovascular disease risk prediction featured image. Cardiovascular. Including ...

  8. Gastroenterology and Hepatology - Clinical trials

    One uncontrolled, unpublished study suggests that a footstool improved bowel ... 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) who are ...

  9. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    1. During the early phases (phases 1 and 2), researchers assess safety, side ... 1 trial. Phase 4 trials look at long-term safety and effectiveness ...

  10. Phase 2 Trial of Blinatumomab in Philadelphia Positive/BCR-ABL Positive Acute Lymphoblastic Leukemia - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety ... release syndrome, febrile neutropenia, and ... release syndrome [CRS] and neurological events ...